MedPath

A Clinical Trial to Study the Effect of Salsaradi Gana Bhavit Haritaki in Patients with High Glucose Levels in Blood.

Phase 2
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/07/054652
Lead Sponsor
Government Akhandanand Ayurveda College, Ahmedabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either sex in the age group of above 18 years and below 65 years.

2.Classical signs and symptoms of Prameha.

3.Fasting plasma glucose <= 200 mg/dl, Post Prandial glucose level <= 300 mg/dl.

4.Both insulin-dependent and non-insulin-dependent Type â?? II Diabetes Mellitus patients will be included.

5.Both newly diagnosed patients on allopathic treatment will be included in this study.

6.The dose of Modern Medicine will be adjusted and tapered during the period of trial as per need.

7.Patients having BMI (Body Mass Index) >= 25 and <= 35 will be taken for the study.

Exclusion Criteria

1.Patients of either sex in the age group of above 18 years and below 65 years.

2.Classical signs and symptoms of Prameha.

3.Fasting plasma glucose <= 200 mg/dl, Post Prandial glucose level <= 300 mg/dl.

4.Both insulin-dependent and non-insulin-dependent Type â?? II Diabetes Mellitus patients will be included.

5.Both newly diagnosed patients on allopathic treatment will be included in this study.

6.The dose of Modern Medicine will be adjusted and tapered during the period of trial as per need.

7.Patients having BMI (Body Mass Index) >= 25 and <= 35 will be taken for the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in laboratorial parameters as well as signs and symptoms of Sthoola Pramehi (Type â?? II Diabetes Mellitus).Timepoint: 40 Days
Secondary Outcome Measures
NameTimeMethod
To improve quality of life by reducing high blood glucose level.Timepoint: 40 days
© Copyright 2025. All Rights Reserved by MedPath